Triumph Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Sell |
686
-133
| -16% | -$53.9K | 0.08% | 233 |
|
|
2025
Q1 | $408K | Sell |
819
-1
| -0.1% | -$498 | 0.14% | 179 |
|
|
2024
Q4 | $427K | Sell |
820
-143
| -15% | -$74.4K | 0.15% | 169 |
|
|
2024
Q3 | $596K | Buy |
963
+143
| +17% | +$88.5K | 0.21% | 123 |
|
|
2024
Q2 | $454K | Sell |
820
-3
| -0.4% | -$1.66K | 0.18% | 135 |
|
|
2024
Q1 | $475K | Sell |
823
-150
| -15% | -$86.6K | 0.19% | 118 |
|
|
2023
Q4 | $517K | Sell |
973
-94
| -9% | -$49.9K | 0.22% | 96 |
|
|
2023
Q3 | $540K | Sell |
1,067
-106
| -9% | -$53.7K | 0.25% | 96 |
|
|
2023
Q2 | $612K | Buy |
1,173
+40
| +4% | +$20.9K | 0.28% | 77 |
|
|
2023
Q1 | $653K | Sell |
1,133
-450
| -28% | -$259K | 0.33% | 58 |
|
|
2022
Q4 | $872K | Sell |
1,583
-580
| -27% | -$319K | 0.47% | 42 |
|
|
2022
Q3 | $1.1M | Buy |
2,163
+236
| +12% | +$120K | 0.6% | 39 |
|
|
2022
Q2 | $1.05M | Sell |
1,927
-172
| -8% | -$93.5K | 0.55% | 43 |
|
|
2022
Q1 | $1.24M | Buy |
+2,099
| New | +$1.24M | 0.54% | 40 |
|